NCT03140774View on ClinicalTrials.gov

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

July 10, 2020

Study Completion Date

July 10, 2020

Conditions
Ebola Virus Disease
Interventions
BIOLOGICAL

Previously exposed to Ebola vaccine

Exposure of interest: participants must have had one or more previous Ebola vaccines, Ad26.ZEBOV , MVA-BN-Filo or r-VSV-ZEBOV to enter the study.

Trial Locations (2)

G61 1QH

MRC - University of Glasgow Centre for Virus Research, Glasgow

OX3 7LJ

Oxford Vaccine Group, University of Oxford, Oxford

All Listed Sponsors
collaborator

University of Glasgow

OTHER

lead

University of Oxford

OTHER

NCT03140774 - Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines | Biotech Hunter | Biotech Hunter